Jenna DiRito
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jenna DiRito has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
- Gregory T. Tietjen
Department of Surgery Yale School of Medicine New Haven Connecticut USA
7 shared publications - Sarah A. Hosgood
Department of Surgery, University of Cambridge, Addenbrooke’s Hospital, Cambridge, United Kingdom
4 shared publications - William Mark Saltzman
Yale University
4 shared publications Jordan S. Pober
Department of Immunobiology, Yale University, New Haven, Connecticut, USA
3 shared publicationsChristopher M. Edwards
Department of Surgery Yale School of Medicine New Haven Connecticut USA
2 shared publicationsDanielle J. Haakinson
Department of Surgery Yale School of Medicine New Haven Connecticut USA
2 shared publications
Latest Publications
- 27 August 2024
- Published by Wiley in Artificial Organs
- Vol. 48 (12) , 1536-1548
Contrast‐enhanced computed tomography for ex vivo assessment of human kidneys: A proof‐of‐concept study
Background: Ex vivo perfusion of transplant‐declined human organs has emerged as a promising platform to study the response of an organ to novel therapeutic strategies. However, to fully realize the capability of this platform for performing translational research in human organ pathophysiology, there is a need for robust assays to assess organ function and disease. State‐of‐the‐art research methods rely on analyses of biopsies taken during perfusion, which both damages the organ and only provides localized information. Developing non‐invasive, whole organ methods of assessment is critical to the further development of this research platform.Methods: We use ex vivo cold infusion scanning (EXCIS) with contrast‐enhanced computed tomography (CT) to quantify perfusion in kidneys preserved ex vivo. EXCIS‐CT computes three complementary metrics for whole organ assessment: a dynamic assessment of contrast filling, a measure of vascular network anatomical structure, and a static assessment of perfusion heterogeneity.Results: These metrics were applied to a series of six transplant‐declined human kidneys, which demonstrated a range of anatomies and perfusion. Lastly, two transplant‐declined human kidneys were imaged before and after a 1‐h period of ex vivo normothermic perfusion (NMP). We found variable responses to NMP, with one kidney maintaining the vascular network and hemodynamics and the other showing significant changes in vessel size and spatial perfusion profile.Conclusions: EXCIS‐CT provides metrics that can be used to characterize whole organ perfusion and vascular function.
- 27 August 2024
- Published by Wiley in Artificial Organs
- Vol. 48 (12) , 1536-1548
Contrast‐enhanced computed tomography for ex vivo assessment of human kidneys: A proof‐of‐concept study
Background: Ex vivo perfusion of transplant‐declined human organs has emerged as a promising platform to study the response of an organ to novel therapeutic strategies. However, to fully realize the capability of this platform for performing translational research in human organ pathophysiology, there is a need for robust assays to assess organ function and disease. State‐of‐the‐art research methods rely on analyses of biopsies taken during perfusion, which both damages the organ and only provides localized information. Developing non‐invasive, whole organ methods of assessment is critical to the further development of this research platform.Methods: We use ex vivo cold infusion scanning (EXCIS) with contrast‐enhanced computed tomography (CT) to quantify perfusion in kidneys preserved ex vivo. EXCIS‐CT computes three complementary metrics for whole organ assessment: a dynamic assessment of contrast filling, a measure of vascular network anatomical structure, and a static assessment of perfusion heterogeneity.Results: These metrics were applied to a series of six transplant‐declined human kidneys, which demonstrated a range of anatomies and perfusion. Lastly, two transplant‐declined human kidneys were imaged before and after a 1‐h period of ex vivo normothermic perfusion (NMP). We found variable responses to NMP, with one kidney maintaining the vascular network and hemodynamics and the other showing significant changes in vessel size and spatial perfusion profile.Conclusions: EXCIS‐CT provides metrics that can be used to characterize whole organ perfusion and vascular function.
- Open Access
- 1 November 2023
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 325 (5) , G379-G390
An optimized visualization and quantitative protocol for in-depth evaluation of lymphatic vessel architecture in the liver
This article showed a comprehensive 3-D-structural analysis of liver lymphatic vessel (LV) in normal and diseased livers in relation to blood vessels and bile ducts. In addition to the LVs highly localized at the portal tract, we revealed capsular LVs in mouse, rat, and human livers. In cholestatic livers, LVs are significantly increased and dilated compared with normal livers. Our optimized protocol provides detailed spatial information for LVs remodeling in normal and pathological conditions.
- 1 November 2023
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 325 (5) , G379-G390
Open AccessAn optimized visualization and quantitative protocol for in-depth evaluation of lymphatic vessel architecture in the liver
This article showed a comprehensive 3-D-structural analysis of liver lymphatic vessel (LV) in normal and diseased livers in relation to blood vessels and bile ducts. In addition to the LVs highly localized at the portal tract, we revealed capsular LVs in mouse, rat, and human livers. In cholestatic livers, LVs are significantly increased and dilated compared with normal livers. Our optimized protocol provides detailed spatial information for LVs remodeling in normal and pathological conditions.
- Open Access
- 7 January 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (2) , 165-170
Honoring the gift: The transformative potential of transplant-declined human organs
- 7 January 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (2) , 165-170
Open AccessHonoring the gift: The transformative potential of transplant-declined human organs
- Open Access
- 6 April 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (4) , e0266218
Surface conjugation of antibodies improves nanoparticle uptake in bronchial epithelial cells
Background: Advances in Molecular Therapy have made gene editing through systemic or topical administration of reagents a feasible strategy to treat genetic diseases in a rational manner. Encapsulation of therapeutic agents in nanoparticles can improve intracellular delivery of therapeutic agents, provided that the nanoparticles are efficiently taken up within the target cells. In prior work we had established proof-of-principle that nanoparticles carrying gene editing reagents can mediate site-specific gene editing in fetal and adult animals in vivo that results in functional disease improvement in rodent models of β-thalassemia and cystic fibrosis. Modification of the surface of nanoparticles to include targeting molecules (e.g. antibodies) holds the promise of improving cellular uptake and specific cellular binding. Methods and findings: To improve particle uptake for diseases of the airway, like cystic fibrosis, our group tested the impact of nanoparticle surface modification with cell surface marker antibodies on uptake in human bronchial epithelial cells in vitro. Binding kinetics of antibodies (Podoplanin, Muc 1, Surfactant Protein C, and Intracellular Adhesion Molecule-1 (ICAM)) were determined to select appropriate antibodies for cellular targeting. The best target-specific antibody among those screened was ICAM antibody. Surface conjugation of nanoparticles with antibodies against ICAM improved cellular uptake in bronchial epithelial cells up to 24-fold. Conclusions: This is a first demonstration of improved nanoparticle uptake in epithelial cells using conjugation of target specific antibodies. Improved binding, uptake or specificity of particles delivered systemically or to the luminal surface of the airway would potentially improve efficacy, reduce the necessary dose and thus safety of administered therapeutic agents. Incremental improvement in the efficacy and safety of particle-based therapeutic strategies may allow genetic diseases such as cystic fibrosis to be cured on a fundamental genetic level before birth or shortly after birth.
- 6 April 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (4) , e0266218
Open AccessSurface conjugation of antibodies improves nanoparticle uptake in bronchial epithelial cells
Background: Advances in Molecular Therapy have made gene editing through systemic or topical administration of reagents a feasible strategy to treat genetic diseases in a rational manner. Encapsulation of therapeutic agents in nanoparticles can improve intracellular delivery of therapeutic agents, provided that the nanoparticles are efficiently taken up within the target cells. In prior work we had established proof-of-principle that nanoparticles carrying gene editing reagents can mediate site-specific gene editing in fetal and adult animals in vivo that results in functional disease improvement in rodent models of β-thalassemia and cystic fibrosis. Modification of the surface of nanoparticles to include targeting molecules (e.g. antibodies) holds the promise of improving cellular uptake and specific cellular binding. Methods and findings: To improve particle uptake for diseases of the airway, like cystic fibrosis, our group tested the impact of nanoparticle surface modification with cell surface marker antibodies on uptake in human bronchial epithelial cells in vitro. Binding kinetics of antibodies (Podoplanin, Muc 1, Surfactant Protein C, and Intracellular Adhesion Molecule-1 (ICAM)) were determined to select appropriate antibodies for cellular targeting. The best target-specific antibody among those screened was ICAM antibody. Surface conjugation of nanoparticles with antibodies against ICAM improved cellular uptake in bronchial epithelial cells up to 24-fold. Conclusions: This is a first demonstration of improved nanoparticle uptake in epithelial cells using conjugation of target specific antibodies. Improved binding, uptake or specificity of particles delivered systemically or to the luminal surface of the airway would potentially improve efficacy, reduce the necessary dose and thus safety of administered therapeutic agents. Incremental improvement in the efficacy and safety of particle-based therapeutic strategies may allow genetic diseases such as cystic fibrosis to be cured on a fundamental genetic level before birth or shortly after birth.
- Open Access
Comparative evaluation of glomerular morphometric techniques reveals differential technical artefacts between FSGS and normal glomeruli
Morphometric estimates of mean glomerular volume (MGV) have clinical implications, over and above histologic data. However, MGV estimation is time-consuming, could waste tissue sections and requires expertise limiting its utility in retrospective clinical studies. Methods We evaluated MGV using both plastic and paraffin-embedded tissue from control and FSGS mice (n=10 each) using the gold-standard Disector/Cavalieri technique (Vglom-Cav) and other reported techniques [2- or 3-profile technique, Weibel-Gomez method (W-G)]. Within Vglom-Cav we examined the precision of MGV estimation while using MGVs obtained from 5- or 10-individual glomeruli measurements vs the true mean (20 glomeruli). Results In both FSGS and controls, we identified an acceptable precision of 10-glomerular sampling vs true MGV within Vglom-Cav technique [88 (79-94) % of MGV obtained were within 10% of the true MGV]. The 5-glomerular sampling was less precise [70 (56, 81) % of MGV obtained were within 10% of true MGV]. In plastic based techniques, 2- or 3-profile MGVs showed greater concordance with Vglom-Cav, than W-G MGV. The new 3-profile technique offered incremental benefit to the existing 2-profile method (improved Lin’s concordance in control and FSGS animals). We observed a consistent reduction of Vglom values within control animals (52+/-0.06%) in paraffin-embedded tissue (vs corresponding methods in plastic) demonstrating a clear shrinkage artefact due to tissue processing. FSGS glomeruli showed significantly less and more variable shrinkage artefact likely due to glomerular fibrosis. Conclusion We report the precision of 5- or 10-glomerular sampling for MGV estimation using controls and FSGS animals. We demonstrate and quantify the shrinkage bias in MGV during tissue processing for paraffin-embedding that also differentiated control animals and FSGS. Our findings have implications for experimental studies using glomerular morphometry.
Open AccessComparative evaluation of glomerular morphometric techniques reveals differential technical artefacts between FSGS and normal glomeruli
Morphometric estimates of mean glomerular volume (MGV) have clinical implications, over and above histologic data. However, MGV estimation is time-consuming, could waste tissue sections and requires expertise limiting its utility in retrospective clinical studies. Methods We evaluated MGV using both plastic and paraffin-embedded tissue from control and FSGS mice (n=10 each) using the gold-standard Disector/Cavalieri technique (Vglom-Cav) and other reported techniques [2- or 3-profile technique, Weibel-Gomez method (W-G)]. Within Vglom-Cav we examined the precision of MGV estimation while using MGVs obtained from 5- or 10-individual glomeruli measurements vs the true mean (20 glomeruli). Results In both FSGS and controls, we identified an acceptable precision of 10-glomerular sampling vs true MGV within Vglom-Cav technique [88 (79-94) % of MGV obtained were within 10% of the true MGV]. The 5-glomerular sampling was less precise [70 (56, 81) % of MGV obtained were within 10% of true MGV]. In plastic based techniques, 2- or 3-profile MGVs showed greater concordance with Vglom-Cav, than W-G MGV. The new 3-profile technique offered incremental benefit to the existing 2-profile method (improved Lin’s concordance in control and FSGS animals). We observed a consistent reduction of Vglom values within control animals (52+/-0.06%) in paraffin-embedded tissue (vs corresponding methods in plastic) demonstrating a clear shrinkage artefact due to tissue processing. FSGS glomeruli showed significantly less and more variable shrinkage artefact likely due to glomerular fibrosis. Conclusion We report the precision of 5- or 10-glomerular sampling for MGV estimation using controls and FSGS animals. We demonstrate and quantify the shrinkage bias in MGV during tissue processing for paraffin-embedding that also differentiated control animals and FSGS. Our findings have implications for experimental studies using glomerular morphometry.
- Open Access
- 5 July 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (1) , 161-173
Lysis of cold-storage-induced microvascular obstructions for ex vivo revitalization of marginal human kidneys
- 5 July 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (1) , 161-173
Open AccessLysis of cold-storage-induced microvascular obstructions for ex vivo revitalization of marginal human kidneys
- 1 June 2019
- Published by Elsevier in Journal of Controlled Release
- Vol. 304, 259-267
Poly(amine-co-ester) nanoparticles for effective Nogo-B knockdown in the liver
- 1 June 2019
- Published by Elsevier in Journal of Controlled Release
- Vol. 304, 259-267
Poly(amine-co-ester) nanoparticles for effective Nogo-B knockdown in the liver
- 29 November 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 9 (418)
Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys
Anti-CD31 antibody conjugation can enhance nanoparticle accumulation in the vascular endothelium of human kidneys during ex vivo normothermic machine perfusion.
- 29 November 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 9 (418)
Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys
Anti-CD31 antibody conjugation can enhance nanoparticle accumulation in the vascular endothelium of human kidneys during ex vivo normothermic machine perfusion.
- 1 August 2017
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 13 (6) , 1863-1867
Quantitative microscopy-based measurements of circulating nanoparticle concentration using microliter blood volumes
- 1 August 2017
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 13 (6) , 1863-1867
Quantitative microscopy-based measurements of circulating nanoparticle concentration using microliter blood volumes